C-reactive protein velocity to distinguish febrile bacterial infections from non-bacterial febrile illnesses in the emergency department.

PubWeight™: 0.76‹?›

🔗 View Article (PMC 2689495)

Published in Crit Care on April 08, 2009

Authors

Yael Paran1, Doron Yablecovitch, Guy Choshen, Ina Zeitlin, Ori Rogowski, Ronen Ben-Ami, Michal Katzir, Hila Saranga, Tovit Rosenzweig, Dan Justo, Yaffa Orbach, Pinhas Halpern, Shlomo Berliner

Author Affiliations

1: Department of Internal Medicine D, E and H, Tel-Aviv Sourasky Medical Center, 6 Weitzman Street, Tel-Aviv 64239, Israel.

Articles citing this

Year in review 2009: Critical Care--infection. Crit Care (2010) 0.76

Articles cited by this

Acute-phase proteins and other systemic responses to inflammation. N Engl J Med (1999) 18.25

Serum procalcitonin and C-reactive protein levels as markers of bacterial infection: a systematic review and meta-analysis. Clin Infect Dis (2004) 6.65

Understanding the inflammatory cytokine response in pneumonia and sepsis: results of the Genetic and Inflammatory Markers of Sepsis (GenIMS) Study. Arch Intern Med (2007) 5.65

Cytokine profiles as markers of disease severity in sepsis: a multiplex analysis. Crit Care (2007) 3.80

Acute myocardial infarction. Lancet (2008) 3.59

Serum cytokine levels in human septic shock. Relation to multiple-system organ failure and mortality. Chest (1993) 2.79

The utility of serum C-reactive protein in differentiating bacterial from nonbacterial pneumonia in children: a meta-analysis of 1230 children. Pediatr Infect Dis J (2008) 1.81

Serum C-reactive protein levels in disease. Ann N Y Acad Sci (1982) 1.75

Use of plasma C-reactive protein, procalcitonin, neutrophils, macrophage migration inhibitory factor, soluble urokinase-type plasminogen activator receptor, and soluble triggering receptor expressed on myeloid cells-1 in combination to diagnose infections: a prospective study. Crit Care (2007) 1.72

Plasma cytokine measurements augment prognostic scores as indicators of outcome in patients with severe sepsis. Shock (2005) 1.71

Can procalcitonin measurement help in differentiating between bacterial infection and other kinds of inflammatory processes? Ann Rheum Dis (2003) 1.58

Serum procalcitonin, C-reactive protein and interleukin-6 for distinguishing bacterial and viral pneumonia in children. Pediatr Infect Dis J (2000) 1.50

Interleukin-6: a sensitive parameter for the early diagnosis of neonatal bacterial infection. Pediatrics (1994) 1.49

Procalcitonin as a marker of bacterial infection in the emergency department: an observational study. Crit Care (2003) 1.46

Procalcitonin, lipopolysaccharide-binding protein, interleukin-6 and C-reactive protein in community-acquired infections and sepsis: a prospective study. Crit Care (2006) 1.34

Performance of a bedside C-reactive protein test in the diagnosis of community-acquired pneumonia in adults with acute cough. Am J Med (2004) 1.22

The role of C-reactive protein in the evaluation and management of infants with suspected sepsis. Adv Neonatal Care (2003) 1.05

Procalcitonin as a marker of bacterial infection. Pediatr Infect Dis J (2000) 1.04

Distinction between bacterial and viral infections. Curr Opin Infect Dis (2007) 0.95

Serum cytokines in differentiating between viral and bacterial enterocolitis. Ann Trop Paediatr (2004) 0.94

C-reactive protein in pneumonia: let me try again. Chest (2004) 0.82

Procalcitonin as a specific marker of bacterial infection in adults. Clin Chem Lab Med (1998) 0.81

Procalcitonin: a bacterial specific marker of infection. Clin Otolaryngol (2007) 0.79

Articles by these authors

Mandatory electrocardiographic screening of athletes to reduce their risk for sudden death proven fact or wishful thinking? J Am Coll Cardiol (2011) 3.86

Clinical and economic impact of bacteremia with extended- spectrum-beta-lactamase-producing Enterobacteriaceae. Antimicrob Agents Chemother (2006) 3.33

Neutrophil/lymphocyte ratio is related to the severity of coronary artery disease and clinical outcome in patients undergoing angiography. Atherosclerosis (2012) 2.38

Update on Pseudomonas aeruginosa and Acinetobacter baumannii infections in the healthcare setting. Curr Opin Infect Dis (2005) 2.10

Burnout and risk of cardiovascular disease: evidence, possible causal paths, and promising research directions. Psychol Bull (2006) 2.01

Erythrocyte aggregation as a cause of slow flow in patients of acute coronary syndromes. Int J Cardiol (2011) 1.94

Is idiopathic ventricular fibrillation a short QT syndrome? Comparison of QT intervals of patients with idiopathic ventricular fibrillation and healthy controls. Heart Rhythm (2004) 1.86

Torsade de pointes due to noncardiac drugs: most patients have easily identifiable risk factors. Medicine (Baltimore) (2003) 1.78

The morphology of the QT interval predicts torsade de pointes during acquired bradyarrhythmias. J Am Coll Cardiol (2007) 1.69

Relation of educational level to inflammation-sensitive biomarker level. Am J Cardiol (2008) 1.64

Predictive value of high sensitivity CRP in patients with diastolic heart failure. Int J Cardiol (2007) 1.63

Provocation of sudden heart rate oscillation with adenosine exposes abnormal QT responses in patients with long QT syndrome: a bedside test for diagnosing long QT syndrome. Eur Heart J (2005) 1.61

Venous and arterial thrombosis following administration of intravenous immunoglobulins. Blood Coagul Fibrinolysis (2005) 1.60

Diagnostic yield of extensive infectious panel testing in acute pericarditis. Cardiology (2011) 1.55

Impact of estimated glomerular filtration rate on vascular disease extent and adverse cardiovascular events in patients without chronic kidney disease. Can J Cardiol (2013) 1.52

Inflammatory bowel disease is not associated with increased intimal media thickening. Am J Gastroenterol (2007) 1.50

Cardiovascular risk factors in men with ischemic heart disease and erectile dysfunction. Urology (2013) 1.47

The "short-coupled" variant of right ventricular outflow ventricular tachycardia: a not-so-benign form of benign ventricular tachycardia? J Cardiovasc Electrophysiol (2005) 1.44

Increased virulence of Zygomycetes organisms following exposure to voriconazole: a study involving fly and murine models of zygomycosis. J Infect Dis (2009) 1.44

Radiofrequency ablation of atrioventricular nodal reentry tachycardia: a 14 year experience with 901 patients at the Tel Aviv Sourasky Medical Center. Isr Med Assoc J (2006) 1.42

Symptomatic venous thromboembolism in elderly patients following major orthopedic surgery of the lower limb is associated with elevated vitamin B12 serum levels. Clin Biochem (2012) 1.39

The prevalence of reversible cardiovascular risk factors in Israelis aged 25-55 years. Isr Med Assoc J (2006) 1.38

The association between burnout, depression, anxiety, and inflammation biomarkers: C-reactive protein and fibrinogen in men and women. J Occup Health Psychol (2005) 1.31

Drug-induced atrioventricular block: prognosis after discontinuation of the culprit drug. J Am Coll Cardiol (2004) 1.28

Active surveillance for methicillin-resistant Staphylococcus aureus (MRSA) decreases the incidence of MRSA bacteremia. Infect Control Hosp Epidemiol (2006) 1.25

Long QT syndrome caused by noncardiac drugs. Prog Cardiovasc Dis (2003) 1.22

Leukocytosis in obese individuals: possible link in patients with unexplained persistent neutrophilia. Eur J Haematol (2006) 1.20

Calcium channel blockers and beta-blockers versus beta-blockers alone for preventing exercise-induced arrhythmias in catecholaminergic polymorphic ventricular tachycardia. Heart Rhythm (2007) 1.20

H1N1 influenza: initial chest radiographic findings in helping predict patient outcome. Radiology (2010) 1.20

Prevalence and risk factors of atherosclerosis in patients with psoriatic arthritis. Semin Arthritis Rheum (2006) 1.17

Epidemiology and sites of involvement of invasive fungal infections in patients with haematological malignancies: a 20-year autopsy study. Mycoses (2013) 1.15

Short-term exposure to air pollution and inflammation-sensitive biomarkers. Environ Res (2007) 1.11

Platelet counts and platelet activation markers in obese subjects. Mediators Inflamm (2008) 1.10

Vitek 2 automated identification system and Kocuria kristinae. J Clin Microbiol (2005) 1.09

Takotsubo cardiomyopathy and QT interval prolongation: who are the patients at risk for torsades de pointes? J Electrocardiol (2009) 1.04

Serum cholinesterase activities distinguish between stroke patients and controls and predict 12-month mortality. Mol Med (2010) 1.04

Prevalence and predictors of concomitant carotid and coronary artery atherosclerotic disease. J Am Coll Cardiol (2011) 1.03

Incidence of cytomegalovirus-associated thrombosis and its risk factors: a case-control study. Thromb Res (2010) 1.03

Corynebacterium striatum--a classic pathogen eluding diagnosis. Eur J Intern Med (2008) 1.03

Platelet inhibitory effect of clopidogrel in patients treated with omeprazole, pantoprazole, and famotidine: a prospective, randomized, crossover study. Clin Cardiol (2013) 1.02

Environmental air pollution has decremental effects on pulmonary function test parameters up to one week after exposure. Am J Med Sci (2009) 1.01

Burnout and risk of coronary heart disease: a prospective study of 8838 employees. Psychosom Med (2012) 0.97

Prevalence of the K65R resistance reverse transcriptase mutation in different HIV-1 subtypes in Israel. J Med Virol (2009) 0.97

MicroRNA-132 modulates cholinergic signaling and inflammation in human inflammatory bowel disease. Inflamm Bowel Dis (2013) 0.97

First report of metronidazole-induced QT interval prolongation. Int J Antimicrob Agents (2007) 0.95

Thrombophilic factors in idiopathic intracranial hypertension: a report of 51 patients and a meta-analysis. Blood Coagul Fibrinolysis (2010) 0.95

Activity of deferasirox in Mucorales: influences of species and exogenous iron. Antimicrob Agents Chemother (2010) 0.94

The interval between prothrombin time tests and the quality of oral anticoagulants treatment in patients with chronic atrial fibrillation. Thromb Res (2006) 0.93

Cholinesterases as biomarkers for parasympathetic dysfunction and inflammation-related disease. J Mol Neurosci (2013) 0.93

The association of higher levels of within-normal-limits liver enzymes and the prevalence of the metabolic syndrome. Cardiovasc Diabetol (2010) 0.92

Drug-induced torsades de pointes in patients aged 80 years or more. Anadolu Kardiyol Derg (2008) 0.92

Prevalence of erectile dysfunction among young adults: results of a large-scale survey. J Sex Med (2004) 0.92

Early signaling of inflammation in acute ischemic stroke: clinical and rheological implications. Thromb Res (2007) 0.91

Low-grade inflammation in individuals with the hypertriglyceridemic waist phenotype: another feature of the atherogenic dysmetabolism. Metabolism (2009) 0.91

Treatment of Crohn's disease with cannabis: an observational study. Isr Med Assoc J (2011) 0.91

Erectile dysfunction might be associated with chronic periodontal disease: two ends of the cardiovascular spectrum. J Sex Med (2008) 0.91

Radiofrequency ablation of accessory pathways: a 14 year experience at the Tel Aviv Medical Center in 508 patients. Isr Med Assoc J (2007) 0.91

Early-mid treatment C-reactive protein level is a prognostic factor in aggressive non-Hodgkin's lymphoma. Eur J Haematol (2007) 0.91

Red blood cell distribution width and 3-year outcome in patients undergoing cardiac catheterization. J Thromb Thrombolysis (2014) 0.90

Micro-inflammatory changes in asymptomatic healthy adults during bouts of respiratory tract infections in the community: potential triggers for atherothrombotic events. Atherosclerosis (2009) 0.90

Elevated resting heart rate is associated with the metabolic syndrome. Cardiovasc Diabetol (2009) 0.89

Erythrocyte adhesiveness/aggregation: a novel biomarker for the detection of low-grade internal inflammation in individuals with atherothrombotic risk factors and proven vascular disease. Am Heart J (2005) 0.88

Vitamin D deficiency prevalence and cardiovascular risk in Israel. Eur J Clin Invest (2010) 0.88

Association of fear of terror with low-grade inflammation among apparently healthy employed adults. Psychosom Med (2004) 0.88

C-reactive protein serum levels as an early predictor of outcome in patients with pandemic H1N1 influenza A virus infection. BMC Infect Dis (2010) 0.87

The effects of physical fitness and feeling vigorous on self-rated health. Health Psychol (2008) 0.87

Exploring the usefulness of inflammation-sensitive biomarkers to reveal potential sex differences in relation to low-grade inflammation in individuals with the metabolic syndrome. Metabolism (2008) 0.87

Association of components of the metabolic syndrome with the appearance of aggregated red blood cells in the peripheral blood. An unfavorable hemorheological finding. Diabetes Metab Res Rev (2005) 0.87

Admission Norton scale scores (ANSS) and postoperative complications following hip fracture surgery in the elderly. Arch Gerontol Geriatr (2011) 0.87

Comparative performance of the Amplicor HIV-1 Monitor Assay versus NucliSens EasyQ in HIV subtype C-infected patients. J Med Virol (2006) 0.86

C-reactive protein to distinguish pneumonia from acute decompensated heart failure. Clin Biochem (2009) 0.86

Circulating interleukin-10: association with higher mortality in systolic heart failure patients with elevated tumor necrosis factor-alpha. Isr Med Assoc J (2010) 0.86

Tacrolimus enhances the potency of posaconazole against Rhizopus oryzae in vitro and in an experimental model of mucormycosis. J Infect Dis (2012) 0.86

Red blood cell distribution width and the risk of cardiovascular morbidity and all-cause mortality. A population-based study. Thromb Haemost (2013) 0.86

Pulmonary hypertension and predominant right heart failure in thyrotoxicosis. Resuscitation (2006) 0.86

A synergistic effect of albumin and fibrinogen on immunoglobulin-induced red blood cell aggregation. Am J Physiol Heart Circ Physiol (2003) 0.85

Glycohaemoglobin as a determinant of increased fibrinogen concentrations and low-grade inflammation in apparently healthy nondiabetic individuals. Clin Endocrinol (Oxf) (2007) 0.85

Thrombosis following acute cytomegalovirus infection: a community prospective study. Ann Hematol (2013) 0.85

Baseline low-density lipoprotein cholesterol levels and outcome in patients with heart failure. Am J Cardiol (2010) 0.85